ENZBOND
EnzBond is an innovative start-up that aims to change the current understanding of biocatalysis. EnzBond has developed an automated In Silico platform that allows rapid optimization of enzymes used for the production of small molecules. Its proprietary technology allows consumers to drop the enzyme discovery cost >10x compared to the current market leaders and compress the discovery time to days.
ENZBOND
Social Links:
Industry:
Biotechnology Developer Platform Innovation Management
Founded:
2016-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.enzbond.com
Total Employee:
1+
Status:
Active
Contact:
+44 7795 231 374
Total Funding:
350 K GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Nginx JsDelivr
Similar Organizations
Aqemia
Drug discovery - neo pharma
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - EnzBond
Official Site Inspections
http://www.enzbond.com
- Host name: 188.166.152.144
- IP address: 188.166.152.144
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
